Urology devices market seen topping $56 billion by 2030

The global urology devices market is projected to reach more than $56 billion by 2030, driven by rising procedure volumes, minimally invasive technology and demand for single-use consumables. Medtronic leads the market now, while North America remains the biggest regional market.

Why it matters: - The urology devices market is expected to exceed $56 billion by 2030, making it a major slice of the broader medical equipment industry. - Growth in the market reflects more kidney stone, urinary incontinence, BPH and bladder cancer procedures, along with faster adoption of robotic and minimally invasive tools. - Consumables are projected to be the largest product category by 2030, signaling strong recurring demand for disposable devices used in routine care and surgery.

What happened: - The market is forecast to grow at a 7% CAGR through 2030. - The forecast places urology devices at about 73% of the larger nephrology and urology devices market, which is expected to reach about $77 billion by 2030. - Within the medical equipment industry, urology devices are projected to represent nearly 5% of a $1,176 billion market by 2030. - Medtronic PLC leads the global market with a 4% share in 2025. - The top 10 companies held 21% of market revenue in 2025, showing a moderately fragmented market.

The details: - North America is expected to remain the largest region, reaching about $18 billion by 2030 from $14 billion in 2025, a 6% CAGR. - The U.S. market is projected to rise to $16 billion by 2030 from $12 billion in 2025, also at a 6% CAGR. - Urology consumables are forecast to account for 31% of the market, or about $17 billion, by 2030. - Other product categories include urology endoscopes, robotic surgical systems, laser systems, lithotripters, brachytherapy systems, high-intensity focused ultrasound systems and urodynamic systems. - The market is also segmented by disease type, including kidney diseases, urological cancers, benign prostatic hyperplasia, pelvic organ prolapse and other conditions. - Hospitals and clinics, dialysis centers and other healthcare facilities are the main end users. - Medtronic’s surgical division offers urological surgical instruments, minimally invasive therapies, implantable devices and related technologies. - Olympus Corporation launched the CH-S700-08-LB 4K camera head in September 2024 for urological and gynecological endoscopy. - The Olympus camera combines 4K white light imaging and Narrow Band Imaging to improve mucosal visualization and support detection of bladder cancer and other conditions. - The market’s leading companies in 2025 included Boston Scientific, Olympus, Cook Medical, Intuitive Surgical, B. Braun, Becton Dickinson, Karl Storz, Teleflex and Lumenis.

Between the lines: - The forecast points to a market where recurring consumable sales may be as important as high-profile capital equipment. - The competitive picture suggests established device makers still control the field, but no single player dominates the market. - Growth drivers such as outpatient treatment, better imaging and AI-assisted procedures suggest that efficiency and precision remain the main buying triggers for providers.

What's next: - The market is expected to add more than $16 billion in value across its main product segments by 2030. - Consumables are projected to add about $5 billion, while urology endoscopes may add $3 billion. - Laser systems and lithotripters are each projected to add $2 billion, and robotic surgical systems, brachytherapy systems, HIFU systems and urodynamic systems are each projected to add about $1 billion. - Further gains are expected from single-use infection-control products, office-based care, outpatient treatments and upgrades in digital visualization, energy delivery and robotics. - The Business Research Company is offering an updated 2026 report with market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards and updated graphics and tables.

The bottom line: - Urology devices are headed for steady, broad-based growth, with consumables, imaging and robotic tools likely to drive the next phase of expansion.